Similar to the pathological features of Caucasian populations with germline high-risk gene mutations50,54, BCDG carriers show distinct clinicopathological features, such as a younger age of onset, a higher Ki67 index, more advanced disease staging, and higher frequencies of bilateral breast cancer and FBOC. The gene discussed is MKI67; the disease is breast carcinoma.